What We're Reading: Page
Industry reads hand-picked by our editors
Aug 24, 2017
-
Kaiser Health News
‘Breakthrough’ leukemia drug also portends ‘quantum leap’ in cost
-
Science
A bold open-access push in Germany could change the future of academic publishing
-
Healthcare Dive
Intermountain plans to cut opioid prescriptions by 40%
-
Regulatory Focus
Patients not always informed of study's purpose in noninferiority trials
Aug 23, 2017
Aug 22, 2017
Aug 21, 2017
-
The Wall Street Journal
How HIV became a cancer cure
-
Financial Times
Hikma hikes price of US medicines by up to 430%
-
Reuters
New Novartis drug takes aim at tough-to-treat malaria
Aug 18, 2017
-
MIT Technology Review
A cancer 'Atlas' to predict how patients will fare
-
The Economist
The search for vaccines against street drugs
-
Bloomberg
Global biotech M&A takes a breather on looming tax reform
Aug 17, 2017
Aug 16, 2017
-
Medical Marketing & Media
Frazier's call earns him praise, rare for a pharma CEO
-
FiveThirtyEight
More vaccines, fewer antibiotics
-
Scientific American
Many pediatric studies are a waste of time
Previous
